Ampio Pharmaceuticals Inc (AMPE)
1.84
+0.00 +0.00%
NYSE AM
Jun 22, 16:59
USD
Ampio Pharmaceuticals Price:
1.84 for June 22, 2021View 4,000+ financial data types
Browse...
View Full Chart
Price Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Price Data
View and export this data going back to 2010.
Start your Free Trial
Export Data
Date Range:
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| June 21, 2021 | 1.89 | 1.92 | 1.80 | 1.84 | 2.982M |
| June 18, 2021 | 1.78 | 1.88 | 1.75 | 1.88 | 2.518M |
| June 17, 2021 | 1.80 | 1.84 | 1.75 | 1.79 | 1.773M |
| June 16, 2021 | 1.86 | 1.899 | 1.78 | 1.80 | 1.995M |
| June 15, 2021 | 1.91 | 1.98 | 1.80 | 1.89 | 9.897M |
| June 14, 2021 | 1.80 | 1.83 | 1.77 | 1.80 | 1.239M |
| June 11, 2021 | 1.75 | 1.815 | 1.748 | 1.78 | 1.179M |
| June 10, 2021 | 1.80 | 1.84 | 1.74 | 1.76 | 1.122M |
| June 9, 2021 | 1.77 | 1.86 | 1.77 | 1.80 | 1.058M |
| June 8, 2021 | 1.80 | 1.85 | 1.77 | 1.79 | 863617.0 |
| June 7, 2021 | 1.77 | 1.85 | 1.765 | 1.79 | 1.545M |
| June 4, 2021 | 1.72 | 1.78 | 1.71 | 1.75 | 920459.0 |
| June 3, 2021 | 1.70 | 1.72 | 1.67 | 1.71 | 1.377M |
| June 2, 2021 | 1.76 | 1.77 | 1.691 | 1.71 | 1.444M |
| June 1, 2021 | 1.82 | 1.84 | 1.75 | 1.77 | 1.408M |
| May 28, 2021 | 1.86 | 1.89 | 1.80 | 1.81 | 750838.0 |
| May 27, 2021 | 1.81 | 1.870 | 1.79 | 1.83 | 1.220M |
| May 26, 2021 | 1.82 | 1.86 | 1.75 | 1.80 | 1.367M |
| May 25, 2021 | 1.90 | 1.94 | 1.85 | 1.85 | 1.075M |
| May 24, 2021 | 1.99 | 1.99 | 1.85 | 1.91 | 1.422M |
| May 21, 2021 | 1.97 | 2.00 | 1.88 | 1.96 | 1.686M |
| May 20, 2021 | 1.90 | 1.99 | 1.85 | 1.95 | 1.992M |
| May 19, 2021 | 1.83 | 1.92 | 1.82 | 1.87 | 1.181M |
| May 18, 2021 | 1.84 | 1.92 | 1.79 | 1.85 | 1.087M |
| May 17, 2021 | 1.74 | 1.87 | 1.74 | 1.84 | 1.197M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Benchmarks
| Eloxx Pharmaceuticals Inc | 1.96 |
| Cyclo Therapeutics Inc | 9.82 |
| NovaBay Pharmaceuticals Inc | 0.67 |
Price Range, Past 5 Years
| Minimum | 0.3481 | Oct 29 2019 |
| Maximum | 4.19 | Dec 28 2017 |
| Average | 1.061 |
Price Related Metrics
| PEG Ratio | -0.0988 |
| Price to Book Value | 21.46 |
| Earnings Yield | -4.35% |
| Market Cap | 360.07M |
| PEGY Ratio | -0.0988 |
News
Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index
PR Newswire 06/18 09:15 ET
PR Newswire 06/18 09:15 ET
Ampio Pharmaceuticals Says New Data Shows Efficacy of Ampion in Patients With Severe Osteoarthritis of the Knee
MT Newswires 06/17 15:25 ET
MT Newswires 06/17 15:25 ET
Ampio highlights integrated data from Ampion osteoarthritis of the knee trials
SA Breaking News 06/17 09:58 ET
SA Breaking News 06/17 09:58 ET
Ampio Pharmaceuticals Gets Regulatory Approval to Expand Enrollment of Mid-Stage Study of Ampion to India
MT Newswires 06/15 06:50 ET
MT Newswires 06/15 06:50 ET
Ampio Pharma stock surge 33% on AP-019 Phase II study expansion to India
SA Breaking News 06/15 06:27 ET
SA Breaking News 06/15 06:27 ET
Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India
PR Newswire 06/15 06:15 ET
PR Newswire 06/15 06:15 ET
Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual Summer Healthcare Symposium
PR Newswire 06/11 09:15 ET
PR Newswire 06/11 09:15 ET
Ampio Wins Investigational Review Board Approval for Phase 1 Long Covid-19 Trial
MT Newswires 05/10 11:07 ET
MT Newswires 05/10 11:07 ET
Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
PR Newswire 05/05 16:01 ET
PR Newswire 05/05 16:01 ET
Ampio Gets FDA Positive Response For Knee Osteoarthritis Treatment Phase III Trial
MT Newswires 04/27 15:02 ET
MT Newswires 04/27 15:02 ET
Advertisement
